Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 19;26(1):17.
doi: 10.1208/s12249-024-03010-6.

Gene Therapy: Towards a New Era of Medicine

Affiliations
Review

Gene Therapy: Towards a New Era of Medicine

Mokshit Bhagat et al. AAPS PharmSciTech. .

Erratum in

  • Correction: Gene Therapy: Towards a New Era of Medicine.
    Bhagat M, Kamal R, Sharma J, Kaur K, Sharma A, Singh TG, Bhatia R, Awasthi A. Bhagat M, et al. AAPS PharmSciTech. 2025 Apr 3;26(4):101. doi: 10.1208/s12249-025-03096-6. AAPS PharmSciTech. 2025. PMID: 40180678 No abstract available.

Abstract

Over the past years, many significant advances have been made in the field of gene therapy and shown promising results in clinical trials conducted. Gene therapy aims at modifying or replacing a defective, inefficient, or nonfunctional gene with a healthy, functional gene by administration of genome material into the cell to cure genetic diseases. Various methods have been devised to do this by using several viral and non-viral vectors which are either administered by in vivo or ex vivo technique. Viral vectors are best suitable for this therapy due to their potential to invade cells and deliver their genetic material whereas non-viral vectors are less efficient than viral vectors but possess some advantages such as less immunogenic response and large gene carrying capacity. Recent advances in biotechnology such as CRISPR-Cas9 mediated genome engineering and Cancer treatment with Chimeric antigen receptor (CAR) T-cell therapy are addressed in this review. This review article also delves into some recent research studies, gene therapy trials, and its applications, laying out future hopes for gene therapy in the treatment of various diseases namely haemophilia, Muscular dystrophy, SCID, Sickle cell disease, Familial Hypercholesterolemia, Cystic Fibrosis. Additionally, it also includes various nanoformulations and clinical trial data related to gene therapy.

Keywords: CAR T-cell; CRISPR-Cas9; gene therapy; gene vectors; genetic disease; viral vectors.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of Interest: None.

References

    1. Bulcha JT, Wang Y, Ma H, Tai PWL, Gao G. Viral vector platforms within the gene therapy landscape. Signal Transduct Target Ther. 2021;6(1):53. - PubMed - PMC
    1. Jensen TL, Gøtzsche CR, Woldbye DPD. Current and future prospects for gene therapy for rare genetic diseases affecting the brain and spinal cord. Front Mol Neurosci. 2021;14:695937. - PubMed - PMC
    1. Deoxyribonucleic Acid (DNA) Fact Sheet https://www.genome.gov/about-genomics/fact-sheets/Deoxyribonucleic-Acid-... . Accessed 10 Jul 2024.
    1. Amaral P, Carbonell-Sala S, De La Vega FM, et al. The status of the human gene catalogue. Nature. 2023;622(7981):41–7. - PubMed - PMC
    1. HaldAlbertsen C, Kulkarni JA, Witzigmann D, Lind M, Petersson K, Simonsen JB. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv Drug Deliv Rev. 2022;188:114416.

LinkOut - more resources